±µºØ²ö¼w¯Ç¬Ì­]¥´°w³B¥i§lª÷Äݪ« ¯u¯à¦¨¡u¸UºÏ¤ý¡v¡H

2021-07-14 1860

³Ìªñ2­Ó¤ë¡AÃþ¦üªº·s»D»P¼v¤ù¦b¥@¬É¦U°ê³Q¼s¬°¶Ç¼½¡A¦]¦¹ªñ´X©P¡A¥@¬É¦U°êªº¬ì¾Ç®a³£¥X¨ÓÅPÁÁ¡C

°ê¤º·s«a¬Ì­]³°Äò¶}©ñ·NÄ@µn°O»P¹w¬ù±µºØ¡A¬Ì­]©ì¥´²vºI¦Ü7¤ë12¤é¡A²Ö­p±µºØ3,821,539¤H¦¸¡A¨ä¤¤AZ¬Ì­]±µºØ2,005,079¤H¦¸¡A²ö¼w¯Ç¬Ì­]±µºØ1,816,460¤H¦¸¡A¥Ø«e·s«a¬Ì­]±µºØ¤H¤f²[»\²v¬°15.93%¡A¦Ü¤Ö±µºØ1¾¯²[»\²v¦³16.27%¡C

ÀHµÛ°ê¤º¥Á²³¬I¥´·s«aªÍª¢¬Ì­]¤H¼Æ³vº¥¼W¥[¡A¶V¨Ó¶V¦h¤H¦b´CÅé¤W©ÎªÀ¸sºô¸ô¤W´y­z¤@¨Ç¦U¦¡¦U¼Ëªº¤£¨}¤ÏÀ³¡A¤]¤Þ°_¤F¤£¤Ö°Q½×¡A¥x¤jÂå°|¥Ö½§³¡¦¶®a·ì±Ð±Â¯S§O±N¬I¥´·s«aªÍª¢¬Ì­]«áªº±`¨£¥Ö½§¤ÏÀ³¾ã²z¦¨°Ýµª¶°¦p¤U¡A·í¤¤¤]¥]§tªñ´Á³Q¼ö¯P°Q½×ªº²ö¼w¯Ç¤âÁu¡B¸UºÏ¤ýµ¥ºô¤Í¼ö·j°ÝÃD¡C

Q1¡G³Ìªñºô¸ô»P·s»D²±¶Ç¥´§¹·s«aªÍª¢¬Ì­]«á¡A¤âÁu³ºµM¯à°÷§l¦í´ö°Í©Î¨ä¥Lª÷Äݪ«ªº·Ó¤ù¡A½Ð°Ý¬O¬I¥´¬Ì­]«áªº°Æ§@¥Î¶Ü¡H

A1¡G¨ä¹ê¤HÅé¥Ö½§¥»¨Ó´N¥i¥H§lªþ¤@¨Ç´ö°Í©Îª÷Äݪ««~¡A¬ÛÃö·s»D±q2008¦~¨ì2016¦~¦b¥@¬É¦U°ê³£¦³³ø¾É¡A¤]¦³³\¦h¬ì¾Ç®a°µ¤F¤@¨Ç¬ã¨s¡AÃÒ¹ê³o¨Ç¨Ã«D¤HÅ馳ºÏ¤O¡A¦Ó¬O¥Ö½§¤Wªº¥Ö¯×©Î¤Àªcª«³y¦¨ªº§lªþ²{¶H¡A¦]¬°¥u­n¦b¥Ö½§¤W¶î©Ù·Æ¥Û¯»«á¡A³o¼Ëªº§lªþ²{¶H´N·|®ø¥¢¡C

³Ìªñ2­Ó¤ë¡AÃþ¦üªº·s»D»P¼v¤ù¦b¥@¬É¦U°ê³Q¼s¬°¶Ç¼½¡A¦]¦¹ªñ´X©P¡A¥@¬É¦U°êªº¬ì¾Ç®a³£¥X¨ÓÅPÁÁ¡A¥]¬A¬ü°ê¯e¯fºÞ¨î§½¡]CDC¡^¡A¥H¤Î½Ñ¦h¼Ú¬ü¬ì¬ã¾÷ºc³£µoÁn©ú»é¥¸¬ÛÃöÁÁ¨¥¡A¤]½Ð¥Á²³¤£­n¥H³_¶Ç³_¡C

Q2¡G¬I¥´·s«aªÍª¢¬Ì­]ªº±`¨£¥Ö½§¤ÏÀ³¦³­þ¨Ç¡H

A2¡G¦b2021¦~7¤ëªº¬ü°ê¥Ö½§¬ìÂå¾Ç·|´Á¥Z¡]*¡^¤¤µoªí¤F¤@½g¥@¬É¦U°ê414¦ì¥Á²³±µ¨ü·s«aªÍª¢mRNA¬Ì­]«á¥Ö½§¤ÏÀ³¡]83%¬I¥´²ö¼w¯Ç¬Ì­]¡B17%¬I¥´½÷·ç¡þBNT¬Ì­]¡^ªº¤ÀªR³ø§i¡A¨ä¤¤³Ì±`¨£ªº4ºØ¥Ö½§°Æ§@¥Î¥]¬A¡G

1.©µ¿ð©Ê¤j«¬§½³¡¤ÏÀ³¡]delayed large local reactions¡^¡A¤S«UºÙ¡u·s«a¤âÁu¡v¡C
2.§½³¡ª`®g³B¤ÏÀ³¡]local injection site reaction¡^¡C
3.ëC³Â¯l¤ÏÀ³¡]urticarial eruptions¡^¡C
4.¥þ¨­©Ê¹L±Ó¯l¡]morbilliform eruptions¡^¡A¤]ºÙ§@¡u³Â¯l¼ËÃĪ«¯l¡v¡C

¨ä¥LÁÙ¦³¤@¨Ç¤ñ¸û¤Ö¨£ªº°Æ§@¥Î¡A¨Ò¦p¡G­á½H¼Ë¯f¨_¡BªÏºÝ¬õµh¯g¡B­ì¦³¥Ö½§¯f´c¤Æ¡Bª´ºÀÁR¯l¡B³æ¯Â疱¯l¡B±aª¬疱¯l¡B¶ñ¥Rª«ª`®g³B¡]¨Ò¦p­ì¥»Áy¤W¥´¹L¬Á§¿»Äªº¦a¤è¡^¬õ¸~µ¥¦U¦¡¦U¼Ëªº¥Ö½§¯l¡C

Q3¡G¤°»ò¬O¡u·s«a¤âÁu¡]COVID arm¡^¡v¡H

A3¡G´N¬O«e­±´£¨ì³Ì±`¨£ªº¥Ö½§¤ÏÀ³¡A¥¿¦¡¦WºÙ¬O¡u©µ¿ð©Ê¤j«¬§½³¡¤ÏÀ³¡v¡A®Ú¾Ú2021¦~7¤ë¥÷¬ü°ê¥Ö½§¬ìÂå¾Ç·|´Á¥Zªº³ø§i¡A¤j¦h¼Æ¬O¦b¬I¥´²ö¼w¯Ç¬Ì­]ªº¤H¤¤¥X²{¡A¥e¥þÅé³q³ø¼Æªº94%¡A¨ä¤¤¤j³¡¤Àªº¤H¡]66%¡^¬O¦b²Ä1¾¯«á²£¥Í¦¹¤ÏÀ³¡A¬ù¦³30%³q³øªÌ¬O¦b²Ä2¾¯«á²£¥Í¡F¦Ü©ó¦b³q³ø¥´½÷·ç¡þBNT¬Ì­]¥X²{¥Ö½§¯lªº¤H¤§¤¤¡A«h¤À§O¦³15%»P18%¦b²Ä1¾¯»P²Ä2¾¯«á¥X²{¦¹¤ÏÀ³¡C

¤£¹L¡A¤j®a¤]¤£»Ý­n¤Ó¾á¤ß¡A¦]¬°¦b²ö¼w¯ÇªºÁ{§É¸ÕÅ礤¡A¦b¥þ³¡¨ü¸ÕªÌ¤¤¥u¦³0.8%ªº¤H¥X²{¡u©µ¿ð©Ê¤j«¬§½³¡¤ÏÀ³¡v¡]**¡^¡C¦Ó¥B³oºØ¤ÏÀ³¦b¬I¥´²Ä2¾¯®É¡Aµo¥Íªº¤ñ²v§ó§C¡C¦¹¥~¡A§Ú­Ì¦b¥xÆW¬I¥´AZ¬Ì­]ªº±Ú¸s¤¤¡A¤]¬Ý¨ì¦n´X¨Ò·s«a¤âÁuªº®×¨Ò¡C

¦¹¤ÏÀ³ªº¯S¼x¬O¤j¬ù¦b¬I¥´·s«aªÍª¢¬Ì­]«á¤j¬ù7¦Ü8¤Ñµo¥Í¡A¦b¥´¹L¬Ì­]ªº¤âÁu¤W·|¸~¤@¤j¥]¡A¤S¸~¤S¼ö¤Sµh¡A¥i¯à·|¦³ÂIÄo¡A«Ü¹³¤j®a¥­±`¼ôª¾ªº¸ÁºÛ©Ê²Õ´ª¢¡C

¥Ø«e±À´ú¡u·s«a¤âÁu¡v¦³¥i¯à¬O¹ï¬Ì­]¤¤ªº½á§Î¾¯¡X¡X»E¤A¤G¾J¡]polyethylene glycol¡^¹L±Ó©Ò³y¦¨¡]***¡^¡A¤@¯ë¤j¬ù3¦Ü4¤Ñ¤§«á´N·|³vº¥®ø°h¡A³Ìªø¬Æ¦Ü¥i¹F25¤Ñ¡C

¤@¯ë«Øij¥i¥H§½³¡¦B¼Å¬õ¸~³¡¦ì¨Ó§ïµ½¯gª¬¡F¦pªG¯uªº«Ü¸~µh¡A¤]¥i¥H¨Ï¥Î¤fªA§Ü²Õ´Ói¥[¥~¥ÎªºÃþ©T¾JÃÄ»I¡A¦³®É¥i¥H¥[¤îµhÃĨӪvÀø¡C¦Ó¥B¡A³o¼Ëªº¤HÁÙ¬O¥i¥H¥´²Ä2¾¯·s«aªÍª¢¬Ì­]¡A¦Ó¥B³q±`²Ä2¦¸¦A¬I¥´¦P¤@ºØ¬Ì­]®É¡AÁöµM·|§ó§Ö¥X²{¬õ¸~¡A¦ý¤Ï¦Ó¯gª¬·|¤ñ¸û»´·L¤]¤ñ¸û§Ö®ø°h¡A¬Æ¦Ü¦³¬ù¤@¥bªº¤H¨S¦³¥X²{·s«a¤âÁu¤ÏÀ³¡C

Q4¡G§Ú¥»¨Ó´N¦³ëC³Â¯l©Î¬O¥Ö½§¹L±Ó¡A¥i¥H¥´·s«aªÍª¢¬Ì­]¶Ü¡H

A3¡GÁöµM¦b±`¨£ªº4ºØ¥Ö½§°Æ§@¥Î¥]¬A¤FëC³Â¯l¤ÏÀ³¡A¦ý¬O¸g¤ñ¹ï¤ÀªR«á¡Aµo²{³o¨Ç°Æ§@¥Îªºµo¥Í»P­ì¥ý³q³øªÌ¬O§_¦³ëC³Â¯l©Î¹L±ÓÅé½èµLª½±µÃö«Y¡C¦]¦¹¡A¥Ø«e»{¬°­ì¥»¦³ëC³Â¯l©Î¥Ö½§Àã¯lªº¤H¡AÁÙ¬O¥i¥H±µ¨ü·s«aªÍª¢¬Ì­]¡C¡]³¯¦pÀ[¡þ¾ã²z³ø¾É¡^

*¥»¬ã¨s¬O¦b¥@¬É¥Ö½§¬ìÂå¾Ç·|Áp·ù¡]ILDS¡^»P¬ü°ê¥Ö½§¬ìÂå¾Ç·|¡]AAD¡^¦X§@¶i¦æªº¥@¬É¦U°ê¬I¥´·s«aªÍª¢¬Ì­]¥Ö½§¤£¨}¤ÏÀ³µn¿ý¨t²Î¤¤¡A±q2020¦~12¤ë¦Ü2021¦~2¤ëªº3­Ó¤ë´Á¶¡¡A¦¬¶°¨ìªº414¨Ò³q³ø­Ó®×¶i¦æ¤ÀªR¡Aµoªí©ó¡m¬ü°ê¥Ö½§¬ìÂå¾Ç·|´Á¥Z¡n¡]JAAD¡^2021¦~7¤ë¸¹¡]J Am Acad Dermatol 2021;85:46-55¡^¡C

**¡m·s­^®æÄõÂå¾Ç´Á¥Z¡n2021¦~2¤ë¸¹¡]N Engl J Med 2021;384:403-16¡^¡C

***¡m¬ü°ê¥Ö½§¬ìÂå¾Ç·|´Á¥Z¯f¨Ò³ø§i¡n¡]JAAD Case Reports¡^2021¦~4¤ë¸¹¡]JAAD Case Reports 2021;10:92-5¡^¡C


¡]¹Ï¡þNOW°·±d»s§@¡F¹Ï¤ù¨Ó·½¡þingimage¡^
¨Ó·½¡G±µºØ²ö¼w¯Ç¬Ì­]¥´°w³B¥i§lª÷Äݪ« ¯u¯à¦¨¡u¸UºÏ¤ý¡v¡H
¥X³B¡GNOW°·±d

ment,'script','//www.google-analytics.com/analytics.js','ga'); ga('create', 'UA-35937129-1', 'auto'); ga('send', 'pageview');